Louis‐Philippe Laurin

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD

Laurence Lepage, A Dufour, Jessica Doiron et al. · Clinical Journal of the American Society of Nephrology · 2015 · 146 citations · Full text

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease

Laura Mariani, Andrew S. Bomback, Pietro A. Canetta et al. · American Journal of Kidney Diseases · 2018 · 131 citations · Full text

Glomerular Disease, Glomerulonephritis, Hemodialysis +10

Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Frank B. Cortazar, John L. Niles, David Jayne et al. · Kidney International Reports · 2023 · 77 citations · Full text

Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease

Louis‐Philippe Laurin, Patrick H. Nachman, Payal Desai et al. · Nephrology Dialysis Transplantation · 2013 · 75 citations · Full text